Harpoon Therapeutics, Inc. (NASDAQ:HARP) Major Shareholder Merck & Co., Inc. Acquires 21,397,205 SharesZolmax • about 1 month ago
Harpoon Therapeutics, Inc. (NASDAQ:HARP Get Free Report) major shareholder Merck & Co., Inc. purchased 21,397,205 shares of the companys stock in a transaction that occurred on Monday...
Share to Feed
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Harpoon Therapeutics, Inc. (Nasdaq: HARP). Harpoon is now a wholly-owned...
HARP's total volume now sits at 6.4M. The +0.17% average daily price change was insignificant these 2 days, leaving HARP's price at $23.01...
Harpoon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Merck...
Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP Get Free Report) have been assigned a consensus rating of Hold from the six research firms that are currently covering the...
HARP's total volume now sits at 1.6M. The +2.27% average daily price change was insignificant these 4 days, leaving HARP's price at $22.93...
This is a signal that HARP's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
HARP's total volume now sits at 5.6M. The +2.41% average daily price change was insignificant these 3 days, leaving HARP's price at $22.96...
HARP's total volume now sits at 2.3M. The +0.89% average daily price change was insignificant these 2 days, leaving HARP's price at $22.62...
This price move could be a signal that HARP may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...